Financial Daily from THE HINDU group of publications
Friday, Apr 23, 2004
Financial Daily from THE HINDU group of publications Friday, Apr 23, 2004 |
||
|
|
||
|
Corporate Results
-
Pharmaceuticals Glenmark Q4 net rises 39 pc Our Bureau
Mumbai , April 22 GLENMARK Pharmaceuticals clocked a 39.5 per cent growth in net profit - from Rs 9.3 crore to Rs 12.98 crore - for the fourth quarter ended March 31, 2004. Sales in this period stood at Rs 114.33 crore, a growth of 4.6 per cent over sales in the same period last year. The company has registered a turnover of Rs 380.66 crore for the year ended March 2004, up 13.3 per cent from Rs 335.89 crore clocked in the financial year ended March 2003. Profit after tax has risen to Rs 42 crore, as compared to Rs 33.19 crore, a growth of 26.5 per cent in the same period. The consolidated profits after accounting for pre-operational expenses of Glenmark's US subsidiary, Glenmark Pharmaceuticals Inc, aggregated Rs 40.79 crore, a company communiqué issued here today said. The company has earlier declared an interim dividend of 65 per cent on equity shares on March 29.
More Stories on : Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|